The Centers for Disease Control and Prevention is warning consumers to stop using EzriCare Artificial Tears as it investigates at least 50 bacterial infections in 11 states that have resulted in permanent vision loss, hospitalization and one death.
The type of infection linked to the drops, Pseudomonas aeruginosa, is resistant to antibiotics and poses a greater threat to those who are immunocompromised. CDC testing determined the bacteria in the products was resistant to antibiotics such as carbapenem, ceftazidime and cefepime.
AARP Membership — $12 for your first year when you sign up for Automatic Renewal
Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine.
Although most infections were linked to the EzriCare brand of eye drops, the CDC hasn’t ruled out that other brands of preservative-free artificial tears may be at risk of contamination. While preservative-free drops are recommended for people who apply artificial tears more than four times a day or have moderate to severe dry eyes, they are more likely to support bacterial growth after the bottle is opened, according to the Mayo Clinic.
Infections were reported in California, Colorado, Connecticut, Florida, New Jersey, New Mexico, New York, Nevada, Texas, Utah and Washington.
In a statement, EzriCare said that it has not received any consumer complaints and has not been asked by any regulatory agency to conduct a recall of any its products. However, in an abundance of caution, the company recommends that consumers discontinue using the product until more details are found.
